Reaction Details Report a problem with these data
Target
Cathepsin D
Ligand
BDBM50302841
Substrate
n/a
Meas. Tech.
ChEMBL_673657 (CHEMBL1274834)
IC50
25±n/a nM
Citation
 Truong, AP; Tóth, G; Probst, GD; Sealy, JM; Bowers, S; Wone, DW; Dressen, D; Hom, RK; Konradi, AW; Sham, HL; Wu, J; Peterson, BT; Ruslim, L; Bova, MP; Kholodenko, D; Motter, RN; Bard, F; Santiago, P; Ni, H; Chian, D; Soriano, F; Cole, T; Brigham, EF; Wong, K; Zmolek, W; Goldbach, E; Samant, B; Chen, L; Zhang, H; Nakamura, DF; Quinn, KP; Yednock, TA; Sauer, JM Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model. Bioorg Med Chem Lett 20:6231-6 (2010) [PubMed]  Article 
Target
Name:
Cathepsin D
Synonyms:
CATD_HUMAN | CPSD | CTSD | Cathepsin D [Precursor] | Cathepsin D heavy chain | Cathepsin D light chain | Cathepsin D precursor
Type:
Enzyme
Mol. Mass.:
44551.72
Organism:
Homo sapiens (Human)
Description:
Human proCathepsin D (SwissProt accession number P07339) was expressed in Sf9 cells, purified, and autoactivated.
Residue:
412
Sequence:
MQPSSLLPLALCLLAAPASALVRIPLHKFTSIRRTMSEVGGSVEDLIAKGPVSKYSQAVPAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQSASSASALGGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL
  
Inhibitor
Name:
BDBM50302841
Synonyms:
CHEMBL571860 | N-((2S,3R)-4-(1-(3-tert-butylphenyl)cyclohexylamino)-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl)acetamide | N-[(1S,2R)-3-{[1-(3-tert-butylphenyl)cyclohexyl]amino}-1-(3,5-difluorobenzyl)-2-hydroxypropyl]acetamide
Type:
Small organic molecule
Emp. Form.:
C28H38F2N2O2
Mol. Mass.:
472.6103
SMILES:
CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNC1(CCCCC1)c1cccc(c1)C(C)(C)C |r|
Structure:
Search PDB for entries with ligand similarity: